Intussusception and rotavirus vaccination: a review of the available evidence
- PMID: 19863248
- DOI: 10.1586/erv.09.106
Intussusception and rotavirus vaccination: a review of the available evidence
Abstract
Two live oral rotavirus vaccines (RotaTeq) and Rotarix) have recently been recommended by the WHO for inclusion into the national immunization programs of countries worldwide. Owing to the association of the withdrawn Rotashield vaccine with intussusception, these two new rotavirus vaccines underwent large clinical trials of over 60,000 infants each to assess safety with regard to this medical condition. For these two new vaccines, clinical trials and available postmarketing safety monitoring data do not indicate a risk of intussusception after vaccination, although a low-level risk cannot be excluded at present. We review these safety data for the new vaccines and for Rotashield to provide background information relevant for considering age recommendations for rotavirus vaccination.
Similar articles
-
Value of Post-Licensure Data on Benefits and Risks of Vaccination to Inform Vaccine Policy: The Example of Rotavirus Vaccines.Am J Prev Med. 2015 Dec;49(6 Suppl 4):S377-82. doi: 10.1016/j.amepre.2015.09.005. Am J Prev Med. 2015. PMID: 26590437 Review.
-
Update on Rotarix: an oral human rotavirus vaccine.Expert Rev Vaccines. 2009 Dec;8(12):1627-41. doi: 10.1586/erv.09.136. Expert Rev Vaccines. 2009. PMID: 19943758 Review.
-
Assessment of postlicensure safety of rotavirus vaccines, with emphasis on intussusception.J Infect Dis. 2009 Nov 1;200 Suppl 1:S282-90. doi: 10.1086/605051. J Infect Dis. 2009. PMID: 19817611
-
Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007.Pediatrics. 2008 Jun;121(6):1206-12. doi: 10.1542/peds.2007-3793. Pediatrics. 2008. PMID: 18519491
-
Postmarketing monitoring of intussusception after RotaTeq vaccination--United States, February 1, 2006-February 15, 2007.MMWR Morb Mortal Wkly Rep. 2007 Mar 16;56(10):218-22. MMWR Morb Mortal Wkly Rep. 2007. PMID: 17363890
Cited by
-
Intussusception risk following oral monovalent rotavirus vaccination in 3 Asian countries: A self-control case series evaluation.Vaccine. 2023 Nov 22;41(48):7220-7225. doi: 10.1016/j.vaccine.2023.10.042. Epub 2023 Oct 24. Vaccine. 2023. PMID: 37884416 Free PMC article.
-
Epidemiology of intussusception among infants in Togo, 2015-2018.Pan Afr Med J. 2021 Jul 29;39(Suppl 1):7. doi: 10.11604/pamj.supp.2021.39.1.21343. eCollection 2021. Pan Afr Med J. 2021. PMID: 34548899 Free PMC article.
-
Global Experience With Rotavirus Vaccines.J Infect Dis. 2021 Dec 20;224(12 Suppl 2):S792-S800. doi: 10.1093/infdis/jiab399. J Infect Dis. 2021. PMID: 34374426 Free PMC article.
-
Intussusception after Rotavirus Vaccine Introduction in India.N Engl J Med. 2020 Nov 12;383(20):1932-1940. doi: 10.1056/NEJMoa2002276. N Engl J Med. 2020. PMID: 33176083 Free PMC article.
-
Assessment of risk of intussusception after pilot rollout of rotavirus vaccine in the Indian public health system.Vaccine. 2020 Jul 14;38(33):5241-5248. doi: 10.1016/j.vaccine.2020.05.093. Epub 2020 Jun 16. Vaccine. 2020. PMID: 32553493 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources